Print page content Print
Increase text size Decrease text size
Text Size

VANGUARD® CV

Helps deliver protection against canine coronavirus

VANGUARD CV

VANGUARD CV is recommended for vaccination of healthy dogs 6 weeks of age or older to help prevent canine coronaviral gastroenteritis.

Collapse All
    • Safety of Vanguard CV was assessed in a field trial in which 5,999 doses were administered.
    • Highly specialized vaccine allows for tailored protocols.
    • In an efficacy study, vaccinated puppies demonstrated significant differences in reduction of clinical signs, virus shed and reduction of diarrhea post-challenge when compared with the control group.
    • Covered by the Companion Animal Immunization Support Guarantee.
  • DIRECTIONS:

    1. General Directions: Vaccination of healthy dogs is recommended. Shake well. Aseptically administer 1 mL subcutaneously or intramuscularly.

    2. Primary Vaccination: Healthy dogs 6 weeks of age or older should receive 2 doses administered 2-3 weeks apart. If dogs are vaccinated before the age of 4 months, they should be revaccinated with a single dose upon reaching 4 months of age. (Maternal antibodies may interfere with development of an adequate immune response in puppies less than 4 months old.)

    3. Revaccination: Annual revaccination with a single dose is recommended.
     


PRECAUTIONS:

1. Store at 2°-7°C. Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze.

2. Use entire contents when first opened.

3. Contains gentamicin as preservative.

4. Vaccination of pregnant bitches should be avoided.

5. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.

6. This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.

Technical inquiries should be directed to Zoetis Veterinary Services, (800) 366-5288 (USA), (800) 461-0917 (Canada).

For veterinary use only.

 

CONTACT US

1-888-963-8471

We are Mon–Fri, 8:30am–8:00pm ET

support@zoetis.com

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2020 Zoetis Services LLC. All rights reserved.